Mitochondrial disease in children
1Mitochondrial Research Group, UCL Great Ormond Street Institute of Child Health, London, UK.
Insights
Childhood mitochondrial diseases are complex, affecting multiple organs and presenting unique diagnostic challenges. Advances in genetic sequencing aid diagnosis, but effective therapies and biomarkers are still needed.
Area of Science:
- Pediatric medicine
- Genetics
- Biochemistry
Background:
- Childhood mitochondrial diseases exhibit significant clinical, biochemical, and genetic heterogeneity.
- Most affected children present with nonclassical, multisystemic disorders rather than canonical syndromes.
- Diagnosis and management are challenging due to unique clinical features and disease trajectories in each child.
Purpose of the Study:
- To review classical childhood mitochondrial syndromes.
- To explore organ-based presentations, including less common ones like skin, hair, and immune dysfunction.
- To outline diagnostic approaches and discuss emerging therapies.
Main Methods:
- Review of classical mitochondrial syndromes in childhood.
- Organ-based perspective on mitochondrial disease manifestations.
- Discussion of diagnostic strategies: clinical evaluation, biochemical, neuroimaging, and genetic investigations.
- Emphasis on next-generation sequencing and functional validation of genetic variants.
Main Results:
- Over 400 genes are now linked to primary mitochondrial disease.
- Next-generation sequencing has advanced diagnostic capabilities.
- Functional validation is crucial for novel genetic variants.
Conclusions:
- Despite progress, significant challenges remain in understanding tissue specificity and clinical variability.
- Disease-modifying therapies and reliable biomarkers for monitoring progression and treatment response are lacking.
- Further research is needed to address unanswered questions in mitochondrial medicine.
Abstract:
Mitochondrial disease presenting in childhood is characterized by clinical, biochemical and genetic complexity. Some children are affected by canonical syndromes, but the majority have nonclassical multisystemic disease presentations involving virtually any organ in the body. Each child has a unique constellation of clinical features and disease trajectory, leading to enormous challenges in diagnosis and management of these heterogeneous disorders. This review discusses the classical mitochondrial syndromes presenting most frequently in childhood and then presents an organ-based perspective including systems less frequently linked to mitochondrial disease, such as skin and hair abnormalities and immune dysfunction. An approach to diagnosis is then presented, encompassing clinical evaluation and biochemical, neuroimaging and genetic investigations, and emphasizing the problem of phenocopies. The impact of next-generation sequencing is discussed, together with the importance of functional validation of novel genetic variants never previously linked to mitochondrial disease. The review concludes with a brief discussion of currently available and emerging therapies. The field of mitochondrial medicine has made enormous strides in the last 30 years, with approaching 400 different genes across two genomes now linked to primary mitochondrial disease. However, many important questions remain unanswered, including the reasons for tissue specificity and variability of clinical presentation of individuals sharing identical gene defects, and a lack of disease-modifying therapies and biomarkers to monitor disease progression and/or response to treatment.
Related Concept Videos
Inborn Errors of Metabolism
Animal Mitochondrial Genetics
Mitochondrial Membranes
ATP Synthase: Mechanism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
The Inner Mitochondrial Membrane


